AI News
 Bonus Features – February 19, 2023 – 80% of orgs collect SDOH data but struggle to make use of it, 2 in 3 cybersecurity pros say their orgs underestimate threats, and more
Healthcare IT Today - (Sunday February 19, 2023) Welcome to the weekly edition of Healthcare IT Today Bonus Features. This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Because there’s so much happening out there in healthcare IT we aren’t able to cover in our full articles, we still want to make sure you’re informed of all the latest news, announcements, and stories happening to help you better do your job.  Weekly Roundup – February 18, 2023
Healthcare IT Today - (Saturday February 18, 2023) Welcome to our Healthcare IT Today Weekly Roundup. Each week, we’ll be providing a look back at the articles we posted and why they’re important to the healthcare IT community. We hope this gives you a chance to catch up on anything you may have missed during the week. |
 What Will Value-Based Drug Pricing Look Like By 2030? Experts Share 4 Predictions
MedCity News - (Saturday February 18, 2023) Editor’s note: This story is based on discussions at Abarca Forward, a conference in San Juan, Puerto Rico, hosted by Abarca, a pharmacy benefit manager. MedCity News’ Editor-in-Chief Arundhati Parmar and Senior Reporter Katie Adams were invited to attend and speak at the conference. All travel and related expenses for the team were covered by Abarca. However, company officials had no input in editorial coverage.  Apellis Drug Becomes First Approved Therapy for Vision-Loss Disorder Geographic Atrophy
MedCity News - (Saturday February 18, 2023) Geographic atrophy, an eye disorder that starts as a loss of central vision and progressively worsens to total blindness, now has its first treatment. The FDA on Friday approved an Apellis Pharmaceuticals drug that slows the progression of this disease, which affects more than 1 million people in the U.S. |
 PBMs Come Under Fire During Senate Hearing
MedCity News - (Saturday February 18, 2023) Pharmacy Benefit Managers (PBMs) took a hit from lawmakers during a Thursday hearing held by the Senate Commerce Committee, with some questioning why the drug middlemen are even necessary.  Are You Ready for HIMSS23?
HIMSS - (Saturday February 18, 2023) Be part of the most exciting week in healthcare at #HIMSS23 in Chicago!HIMSS23 is the can’t-miss health information and technology event of the year, where professionals connect for education, innovation and collaboration.Are you ready?Join us April 17-21, 2023: https://bit.ly/3ke9rip… |
 Decline of Telehealth During the Pandemic and After
MedCity News - (Saturday February 18, 2023) The pandemic has forced healthcare organizations to rely heavily on telehealth services. In 2020, virtual visits accounted for more than a quarter of all outpatient visits in the U.S., and they’ve been steadily increasing since then. But there is a flip side to this trend. Recent data shows that telehealth is declining in healthcare, which could create a burden for both healthcare systems and patients. Let’s take a look at why this is happening and what can be done about it.  Fatty Liver Disease in Children: Prevalence, Evaluation, & Essential Tools
eHealth Radio Network - (Friday February 17, 2023) Dr. Alisha Mavis, a Pediatric Hepatologist at Duke University where she cares for pediatric patients with liver disease joins eHealth Radio and the Children’s Health & Health News Channels. |
 Q&A: Thrive Center’s CEO Makes Staffing Shortage Concerns a Top Priority
HealthTech Magazine - (Friday February 17, 2023) HEALTHTECH: What are the highest-priority issues for senior care organizations in 2023?ROSE: I think it would be workforce and staffing issues, especially in the post-acute area. Unfortunately, because of the COVID-19 pandemic, we saw so many people leave healthcare. Staffing has always been an issue, but it reached critical status during the pandemic. Now, organizations are really trying to recover, so they’re looking for solutions that can augment their workforce and make workflows seamless — not a lot of logins, not a lot of devices, more cloud-based solutions that will really drive efficiency and mobility, because that’s going to be key to a…  Chiesi Wins FDA Approval for First Drug to Treat Ultra-Rare Enzyme Deficiency
MedCity News - (Friday February 17, 2023) A Chiesi Farmaceutici drug for a rare enzyme deficiency is now approved by the FDA, making it the first U.S. treatment for a disorder that leads to a range of cognitive and muscle problems. |
